Targeting gut-microbiota-dependent choline metabolite trimethylamine N-oxide ameliorates bone health in
Huaying Hu1, Xue Dai1, Jinzhao Yang1
1School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
Aims:
Postmenopausal osteoporosis (PMO) arises from estrogen deficiency and imposes a substantial global health burden due to its high fracture risk and related complications. Although choline has been suggested as a nutritional bone-protective factor, its gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) has been reported to exert adverse vascular and metabolic effects, leaving its overall impact on bone health unclear. This study aims to elucidate how choline-derived TMAO regulates bone metabolism under estrogen-deficient conditions and to explore its potential therapeutic value for preventing PMO.
Materials And Methods:
Ovariectomized (OVX) mice were fed a 1% choline diet for nine weeks. Bone microarchitecture was assessed using micro-CT. Tibial gene expression was profiled to identify TMAO-responsive pathways. The involvement of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) pathway was evaluated using the selective PERK inhibitor GSK2606414. Gut microbiota composition was analyzed to determine choline-associated microbial changes.
Key Findings:
Moderate elevation of TMAO derived from dietary choline protected against OVX-induced bone loss. Choline supplementation increased bone volume/tissue volume (BV/TV) and trabecular number (Tb.N), while enriching beneficial gut commensals such as Akkermansia. Transcriptomic analysis showed upregulation of protein-folding and osteogenic signaling, particularly PERK-mediated ER stress responses. Inhibition of PERK markedly worsened bone microarchitecture deterioration, underscoring the central role of the TMAO-PERK axis in skeletal remodeling.
Significance:
These findings reveal a beneficial role of gut microbiota-dependent TMAO formation in mitigating estrogen-deficiency-induced bone loss and suggest that the TMAO-PERK signaling axis may provide new mechanistic insights and research directions for the prevention and intervention of PMO.
